Natural killer cells: Emerging concepts in immunity to infection and implications for assessment of immunodeficiency

Current Opinion in Pediatrics

Volumn 15, Issue 6, 2003, Pages 586-593

  Heusel, Jonathan W ^a   Ballas, Zuhair K ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

DC; Dendritic cells; Immunodeficiency; Innate immunity; Natural killer; NK

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTEGRIN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

CYTOTOXICITY; DENDRITIC CELL; FLOW CYTOMETRY; GRAM POSITIVE BACTERIUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; LISTERIA MONOCYTOGENES; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA MANSONI; T LYMPHOCYTE;

ANIMALS; HUMANS; INFECTION; INTERFERON TYPE II; KILLER CELLS, NATURAL; MODELS, IMMUNOLOGICAL;

EID: 0345603635     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200312000-00008     Document Type: Review

References (93)

1. Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol 2001, 22:633-640.
2. Miller JS: The biology of natural killer cells in cancer, infection, and pregnancy. Exp Hematol 2001, 29:1157-1168.
3. Colucci F, Caligiuri MA, Di Santo JP: What does it take to make a natural killer? Nat Rev Immunol 2003, 3:413-425. A comprehensive review of NK cell development, providing much needed clarification and fresh insight to the topic.
4. Yokoyama WM, Scalzo AA: Natural killer cell activation receptors in innate immunity to infection. Microbes Infection 2002, 4:1513-1521.
5. Arase H, Lanier LL: Virus-driven evolution of natural killer cell receptors. Microbes Infection 2002, 4:1505-1512.
6. Moser JM, Byers AM, Lukacher AE: NK cell receptors in antiviral immunity. Curr Opin Immunol 2002, 14:509-516.
7. French AR, Yokoyama WM: Natural killer cells and viral infections. Curr Opin Immunol 2003, 15:45-51.
8. Lanier LL: Natural killer cell receptor signaling. Curr Opin Immunol 2003, 15:308-314.
9. Colucci F, Di Santo JP, Leibson PJ: Natural killer cell activation in mice and men: different triggers for similar weapons? Nat Immunol 2002, 3:807-813.
10. Natarajan K, Dimasi N, Wang J, et al.: Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 2002, 20:853-885.
11. Raulet DH, Vance RE, McMahon CW: Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001, 19:291-330.
12. Orange JS: Human natural killer cell deficiencies and susceptibility to infection. Microbes Infection 2002, 4:1545-1558. A scholarly synthesis of immunodeficiency, highlighting the importance of NK cells in a wide variety of diseases. This review forms the solid foundation of a growing appreciation for NK cell function across clinical disciplines.
13. Smyth MJ, Hayakawa Y, Takeda K, et al.: New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2002, 2:850-861.
14. Yokoyama WM, Plougastel BF: Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003, 3:304-316.
15. Diefenbach A, Raulet DH: Innate immune recognition by stimulatory immunoreceptors. Curr Opin Immunol 2003, 15:37-44.
16. Moretta L, Bottino C, Pende D, et al.: Human natural killer cells: their origin, receptors and function. Eur J Immunol 2002, 32:1205-1211.
17. Biron CA, Brossay L: NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 2001, 13:458-464.
18. Smyth MJ, Crowe NY, Hayakawa Y, et al.: NKT cells-conductors of tumor immunity? Curr Opin Immunol 2002, 14:165-171.
19. Yu H, Fehniger TA, Fuchshuber P, et al.: Flt3 ligand promotes the generation of a distinct CD34+ human natural killer cell progenitor that responds to interleukin-15. Blood 1998, 92:3647-3657.
20. Rosmaraki EE, Douagi I, Roth C, et al.: Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol 2001, 31:1900-1909.
21. Mrozek E, Anderson P, Caligiuri M: Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 1996, 87:2632-2640.
22. Kennedy MK, Glaccum M, Brown SN, et al.: Reversible defects In natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000, 191:771-780.
23. Ranson T, Vosshenrich CAJ, Corcuff E, et al.: IL-15 is an essential mediator of peripheral NK cell homeostasis. Blood 2003, 101:4887-4893.
24. Cooper MA, Bush JE, Fehniger TA, et al.: In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 2002, 100:3633-3638. An interesting study that demonstrated differential cytokine responsiveness between the two major human NK cell populations.
25. lo NK precursors may contribute disproportionately to regeneration of peripheral NK cells after biological depletions.
26. Fehniger TA, Caligiuri MA: Interleukin 15: biology and relevance to human disease. Blood 2001, 97:14-32.
27. Toomey JA, Gays F, Foster D, et al.: Cytokine requirements for the growth and development of mouse NK cells in vitro. J Leukoc Biol 2003, 74:233-242.
28. Barao I, Hudig D, Ascensao JL: IL-15-mediated induction of LFA-1 is a late step required for cytotoxic differentiation of human NK cells from CD34+Linbone marrow cells. J Immunol 2003, 171:683-690.
29. Kim S, Iizuka K, Kang HS, et al.: In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002, 3:523-528. A technically demanding analysis of NK cell developmental stages in adult mouse bone marrow, establishing the utility of Mac-1 in discriminating immature from mature NK cells.
30. Noguchi M, Yi H, Rosenblatt HM, et al.: Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993, 73:147-157.
31. Gilmour KC, Fujii H, Cranston T, et al.: Defective expression of the interteukin-2/interleukin-15 receptor {beta} subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency. Blood 2001, 98:877-879.
32. Leonard WJ: Cytokines and immunodeficiency diseases. Nat Rev Immunol 2001, 1:200-208.
33. Yokota Y, Mansouri A, Mori S, et al.: Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor ld2. Nature 1999, 397:702-706.
34. Ikawa T, Fujimoto S, Kawamoto H, et al.: Commitment to natural killer cells requires the helix-loop-helix inhibitor ld2. Proc Natl Acad Sci U S A 2001, 98:5164-5169.
35. Hara H, Wada T, Bakal C, et al.: The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 2003, 18:763-775. Reports that deficiency in a plasma membrane-associated kinase (CARD11) is required for efficient receptor-mediated signaling through NF-κB and, surprisingly, selectively affects NK cell development.
36. Lanier LL, Le AM, Civin CI, et al.: The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986, 136:4480-4486.
37. Cooper MA, Fehniger TA, Turner SC, et al.: Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood 2001, 97:3146-3151.
38. Robertson MJ: Role of chemokines in the biology of natural killer cells. J Leukoc Biol 2002, 71:173-183. An exhaustive analysis and discussion of chemokine biology as it applies to NK cells.
39. Norwitz ER, Schust DJ, Fisher SJ: Implantation and the survival of early pregnancy. N Engl J Med 2001, 345:1400-1408.
40. Croy BA, He H, Esadeg S, et al.: Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling. Reproduction 2003, 126:149-160.
41. Barber EM, Pollard JW: The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a Listeria monocytogenes infection. J Immunol 2003, 171:37-46.
42. Chantakru S, Miller C, Roach LE, et al.: Contributions from self-renewal and trafficking to the uterine NK cell population of early pregnancy. J Immunol 2002, 168:22-28. A technically difficult study that implicates peripheral tissues as a source for NK cell precursors and further delineates the molecular parameters of uterine NK cell trafficking.
43. Helander TS, Timonen T: Adhesion in NK cell function. Curr Topics Microbiol Immunol 1998, 230:89-99.
44. Lejtenyi D, Osmond DG, Miller SC: Natural killer cells and B lymphocytes in L-selectin and Mac-1/LFA-1 knockout mice: marker-dependent, but not cell lineage-dependent changes in the spleen and bone marrow. Immunobiology 2003, 207:129-135.
45. Lin SJ, Chang LY, Yan DC, et al.: Decreased intercellular adhesion molecule-1 (CD54) and L-selectin (CD62L) expression on peripheral blood natural killer cells in asthmatic children with acute exacerbation. Allergy 2003, 58:67-71.
46. Riteau B, Barber DF, Long EO: Vav1 phosphorylation is induced by {beta}2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J Exp Med 2003, 198:469-474. This paper is an exemplary synthesis across the fields of integrin-mediated signaling and NK cell effector function, and provides a molecular basis for understanding the fundamental contribution of LFA-1 to lymphocyte function.
47. Drake PM, Gunn MD, Charo IF, et al.: Human placental cytotrophoblasts attract monocytes and CD56bright natural killer cells via the actions of monocyte inflammatory protein 1 {alpha}. J Exp Med 2001, 193:1199-1212.
48. Chantakru S, Kuziel WA, Maeda N, et al.: A study on the density and distribution of uterine natural killer cells at mid pregnancy in mice genetically-ablated for CCR2, CCR 5 and the CCR5 receptor ligand, MIP-1 alpha. J Reprod Immunol 2001, 49:33-47.
49. Hanna J, Wald O, Goldman-Wohl D, et al.: CXCL12 expression by invasive trophoblasts induces the specific migration of CD16 negative human natural killer cells. Blood 2003, 102:1569-1577. A thorough dissection of decidual NK cell chemokine receptor profiles and responsiveness that identifies CXCR4 as a critical receptor involved in recruitment of human uterine NK cells in response to CXCL12 produced by extravillous fetal trophoblast.
50. Barlic J, Sechler JM, Murphy PM: IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1. Blood 2003, EPub ahead of print.
51. Dorner BG, Scheffold A, Rolph MS, et al.: MIP-1 alpha, MIP-1 beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc Natl Acad Sci U S A 2002, 99:6181-6186. A convincing demonstration of the coordinated secretion of IFN-γ together with MIP-1α/CCL3, MIP-1β/CCL4, RANTES/CCL5 and ATAC/lymphotactin as a functional unit, and the cooperative effects these cytokines and chemokines have upon antigen-presenting cells.
52. Beider K, Nagler A, Wald O, et al.: Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. Blood 2003, 102:1951-1958.
53. Hernandez PA, Gorlin RJ, Lukens JN, et al.: Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003, 34:70-74. First report of human immunodeficiency associated with aberrant chemokine receptor function; the predominant susceptibility to HPV infection raises suspicion for an associated defect in NK cell numbers or function.
54. Takeda K, Akira S: Toll receptors and pathogen resistance. Cell Microbiol 2003, 5:143-153.
55. Hornung V, Rothenfusser S, Britsch S, et al.: Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002, 168:4531-4537. First reported comprehensive analysis of TLR expression in NK cells, in which mRNA expression does not necessarily correlate with NK cell responsiveness, as was shown for TLR-9.
56. Picard C, Puel A, Bonnet M, et al.: Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003, 299:2076-2079. First report of human mutation in the common IL-1/IL-18/TLR signal transduction pathway, which results in failure to respond to IL-1, IL-18, and known ligands for TLR1-6 and TLR-9 and is associated with an immunodeficiency with particular susceptibility to gram-positive bacteria.
57. Orange JS, Brodeur SR, Jain A, et al.: Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest 2002, 109:1501-1509. This report describes several patients with mutations in NEMO/IKKγ who present with recurrent viral infections and an immunodeficiency associated with defective direct NK cell cytotoxicity (natural killing), but normal NK cell numbers and antibody-dependent cellular cytotoxicity function.
58. Lande R, Giacomini E, Grassi T, et al.: IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J Immunol 2003, 170:1174-1182.
59. Shang X, Qiu B, Frait KA, et al.: Chemokine receptor 1 knockout abrogates natural killer cell recruitment and impairs type-1 cytokines in lymphoid tissue during pulmonary granuloma formation. Am J Pathol 2000, 157:2055-2063.
60. Maghazachi AA: G protein-coupled receptors in natural killer cells. J Leukoc Biol 2003, 74:16-24.
61. Peters W, Dupuis M, Charo IF: A mechanism for the impaired IFN-{gamma} production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses. J Immunol 2000, 165:7072-7077.
62. Serbina NV, Salazar-Mather TP, Biron CA, et al.: TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59-70. This report uncovers an unusual population of DC that make tumor necrosis factor-α and inducible nitric oxide synthase during bacterial infection; these Tip-DC are lacking in CCR2-deficient mice, which implicates CCR2 in the recruitment and/or local differentiation of this particular DC subset.
63. Webb JR, Lee SH, Vidal SM: Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match. Genes Immunity 2002, 3:250-262.
64. Tay CH, Welsh RM: Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol 1997, 71:267-275.
65. Salazar-Mather TP, Hamilton TA, Biron CA: A chemokine-to-cytokine-to- chemokine cascade critical in antiviral defense. J Clin Invest 2000, 105:985-993.
66. Daniels KA, Devora G, Lai WC, et al.: Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med 2001, 194:29-44. Reference 66 clearly demonstrated that the MCMV resistance locus, Cmv1, encodes the NK cell activating receptor, Ly-49H, ending a decade-long search for a gene that directs a critical NK cell-mediated response to a well characterized viral infection.
67. Brown MG, Dokun AO, Heusel JW, et al.: Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001, 292:934-937. Reference 67 clearly demonstrated that the MCMV resistance locus, Cmv1, encodes the NK cell activating receptor, Ly-49H, ending a decade-long search for a gene that directs a critical NK cell-mediated response to a well characterized viral infection.
68. Lee SH, Girard S, Macina D, et al.: Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily [comment]. Nat Genet 2001, 28:42-45.
69. Arase H, Mocarski ES, Campbell AE, et al.: Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors [comment]. Science 2002, 296:1323-1326. See annotation to ref. 70.
70. Smith HR, Heusel JW, Mehta IK, et al.: Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 2002, 99:8826-8831. These two reports simultaneously identified the ligand for Ly-49H, which is the MCMV-encoded product, m157. These observations demonstrated unexpected, exquisite specificity between an innate immune cell surface receptor and a viral gene product, providing the basis from which the parameters of NK cell activation to a physiologic stimulus may be dissected.
71. Dokun AO, Kim S, Smith HR, et al.: Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2001, 2:951-956.
72. + DC) not only cooperate in response to MCMV infection, but also are critically dependent on each other, providing the basis to investigate subset specialization among innate immune cells.
73. Dalod M, Hamilton T, Salomon R, et al.: Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med 2003, 197:885-898. Identifies plasmacytoid DC as a major source of type I interferon (IFN-αβ) early in MCMV infection and demonstrates differential infectivity of DC subsets by MCMV.
74. Andrews DM, Andoniou CE, Granucci F, et al.: Infection of dendritic cells by murine cytomegalovirus induces functional paralysis [comment]. Nat Immunol 2001, 2:1077-1084.
75. Gerosa F, Baldani-Guerra B, Nisii C, et al.: Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002, 195:327-333. This report establishes functional reciprocal interactions between human DC and NK cells that provide for NK cell activation and DC maturation.
76. Krug A, Uppaluri R, Facchetti F, et al.: IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J Immunol 2002, 169:6079-6083. CXCL12 and CXCR4 are identified as mediators of a positive feedback loop that involves interferon-producing DC in humans and mice, which may represent an important mechanism for assembly of activated antigen-presenting "DC clusters" within secondary lymphoid tissue.
77. Kos FJ: Regulation of adaptive immunity by natural killer cells. Immunol Res 1998, 17:303-312.
78. Kelly JM, Darcy PK, Markby JL, et al.: Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 2002, 3:83-90. This report describes an alternative pathway for T-cell sensitization against tumor cells that is dependent upon NK cells activated through CD27, perform and the production of IFN-γ.
79. Diefenbach A, Raulet DH: The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol Rev 2002, 188:9-21.
80. Strbo N, Oizumi S, Sotosek-Tokmadzic V, et al.: Perform is required for innate and adaptive immunity induced by heat shock protein gp96. Immunity 2003, 18:381-390. An elegant study that identifies NK cells as the source for perform that, along with IFN-γ, is required for tumor antigen-specific T-cell immunity through a mechanism similar (or identical) to that in described ref. 78.
81. Badovinac VP, Tvinnereim AR, Harty JT: Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. Science 2000, 290:1354-1357.
82. Rabinovich BA, Li J, Shannon J, et al.: Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J Immunol 2003, 170:3572-3576. This report may be the first definitive demonstration that NK cells can kill activated T cells; T-cell sensitivity to NK cell lysis was transient, brefeldin A-sensrtive, and involved induction of undetermined ligand(s) for the NKG2D activation receptor.
83. Ferlazzo G, Morandi B, D'Agostino A, et al.: The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 2003, 33:306-313.
84. Ruggeri L, Capanni M, Urbani E, et al.: Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002, 295:2097-2100. A detailed follow-up study from a previous report describing NK cell alloreactivity in the setting of allogeneic hematopoietic stem cell transplantation, in which donor-derived NK cells exert beneficial effects of reduced graft-vs.-host disease and graft-vs.-leukemia. This paper describes a mouse model of NK alloreactivity that implicates a mechanism for these effects-donor NK cell-mediated elimination of host myeloid cells, including DC and myeloid leukemic blasts.
85. Ferlazzo G, Tsang ML, Moretta L, et al.: Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002, 195:343-351.
86. Castriconi R, Cantoni C, Della Chiesa M, et al.: Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci U S A 2003, 100:4120-4125.
87. Latour S, Veillette A: Molecular and immunological basis of X-linked lymphoproliferative disease. Immunol Rev 2003, 192:212-224.
88. Trapani JA, Smyth MJ: Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002, 2:735-747.
89. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al.: Perform gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999, 286:1957-1959.
90. Sayos J, Wu C, Morra M, et al.: The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM [comment]. Nature 1998, 395:462-469.
91. Nichols KE, Harkin DP, Levitz S, et al.: Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. PNAS 1998, 95:13765-13770.
92. Coffey AJ, Brooksbank RA, Brandau O, et al.: Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene [comment]. Nat Genet 1998, 20:129-135.
93. Badovinac VP, Hamilton SE, Harty JT: Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice. Immunity 2003, 18:463-474. A surprising discovery that perforin-deficient mice unexpectedly die after a secondary viral antigen challenge; the uncontrolled CD8 T-cell expansion in perforin-deficient mice resembles human cases of hemophagocytic lymphohistiocytosis.